EcoR1 Capital LLC 13D and 13G filings for Eton Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 1:04 pm Purchase |
2024-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON |
EcoR1 Capital LLC | 1,981,003 7.700% |
583,334 (+41.74%) |
Filing |
| 2024-12-09 4:04 pm Purchase |
2024-12-02 | 13G | Eton Pharmaceuticals, Inc. ETON |
EcoR1 Capital LLC | 1,397,669 5.400% |
1,397,669 (New Position) |
Filing |